Coronavirus-Mozambique: The United States Donates Additional 2 Million Johnson & Johnson Vaccines to Mozambique
The U.S. Embassy in Mozambique announces the arrival of 2,016,000 doses of the Johnson & Johnson vaccine that the United States is sharing with the Republic of Mozambique through COVAX. This is the United States’ fourth and largest bi-lateral COVID-19 vaccine delivery to Mozambique, bringing the total number of U.S.-donated vaccines to nearly 3.5 million, and maintaining the United States as Mozambique’s largest bi-lateral vaccine donor.
“The United States remains committed to sharing vaccines equitably, around the world,” U.S. Ambassador to Mozambique Dennis W. Hearne said. “No one is protected from COVID-19 until everyone is vaccinated. As more vaccines become available to all nations around the world, we have a shared interest in getting everyone who is eligible vaccinated.”
The U.S. Government has provided early and ongoing support for the response to the COVID-19 pandemic in Mozambique, including assistance valued at $62.5 million. This assistance includes the recent donation of 60 oxygen cylinders and a PSA oxygen plant, 50 ventilators, personal protective equipment for healthcare workers, laboratory and oxygen equipment, training, and funding for increased medical staff, among other initiatives. For more information on U.S. support for Mozambique’s efforts to combat COVID-19, visit this link.
In close collaboration with the Government of the Republic of Mozambique, the U.S. Government provides more than $500 million in annual assistance to improve the quality of education and healthcare, promote economic prosperity, and support the overall development of the nation.
Distributed by APO Group on behalf of U.S. Embassy in Mozambique.